Genetic correlates of prostate cancer visibility (and invisibility) on multiparametric magnetic resonance imaging: it's time to take stock
BJU Int
.
2020 Mar;125(3):340-342.
doi: 10.1111/bju.14919.
Epub 2019 Dec 20.
Authors
Joseph M Norris
1
2
3
,
Benjamin S Simpson
1
,
Marina A Parry
4
,
Veeru Kasivisvanathan
1
2
3
5
,
Clare Allen
6
,
Rhys Ball
7
,
Alex Freeman
7
,
Daniel Kelly
8
,
Alex Kirkham
6
,
Hayley C Whitaker
1
,
Mark Emberton
1
2
Affiliations
1
Unviersity College London (UCL) Division of Surgery and Interventional Science, UCL, London, UK.
2
London Deanery of Urology, London, UK.
3
Department of Urology, University College London Hospitals NHS Foundation Trust (UCLH), London, UK.
4
UCL Cancer Institute, UCL, London, UK.
5
Department of Urology, Frimley Health NHS Foundation Trust, London, UK.
6
Department of Radiology, UCLH, London, UK.
7
Department of Pathology, UCLH, London, UK.
8
School of Healthcare Sciences, Cardiff University, Wales, UK.
PMID:
31600865
DOI:
10.1111/bju.14919
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Correlation of Data
Humans
Male
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms / diagnostic imaging*
Prostatic Neoplasms / genetics*
Grants and funding
27935/CRUK_/Cancer Research UK/United Kingdom
MR/M009092/1/MRC_/Medical Research Council/United Kingdom
MR/S00680X/1/MRC_/Medical Research Council/United Kingdom